To conclude, our present observations state that curcumin treatment potentially inhibits the proliferation of BxPC-3 human pancreatic cancer cells by DNA damage-mediated G2/M cell cycle arrest by the activation of ATM/Chk1/Cdc25C and inhibition of cyclin B1/Cdk1 expression. Here, CDC25C is linked to pancreatic neoplasm.